結構性心臟閉塞設備的全球市場 - 市場規模(各市場區隔)，佔有率，法規，償付，治療，預測(～2033年)

本報告提供全球結構性心臟閉塞設備市場相關調查分析，提供各市場區隔的市場規模，市場趨勢，競爭情形，COVID-19影響等資訊。

市場模式的主要的內容如下列。

目前上市的結構性心臟閉塞設備和不斷變化的競爭格局

• 主要的產業趨勢考察
• 結構性心臟閉塞設備市場區隔的年度收益與市場預測(2015年～2033年)
• 有關各市場區隔的整體治療數量，單位，平均銷售價格，市場金額的詳細資料

世界，地區，國家層級的市場具體考察

• 各地區分類的定性市場具體資訊各國考察與全球趨勢
• 結構性心臟閉塞設備市場SWOT分析
• 結構性心臟閉塞設備市場競爭動態的考察和趨勢

透過取得真正的大局（包括醫療保健系統的概述）來促進對市場的了解。此外，市場准入部分可讓您透過有關報銷政策和監管環境的資訊更深入地了解市場動態。

• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規形勢

對象企業

• Boston Scientific Corp
• Abbott Laboratories
• AtriCure Inc
• Lifetech Scientific Corporation
• Occlutech GmbH
• pfm medical ag
• W. L. Gore & Associates Inc
• 其他

Abstract

Structural Heart Occlusion Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Structural Heart Occlusion Devices market for the year 2020 and beyond. Congenital Heart Disease (CHD) is structural heart defects ranging in severity that are present at birth. Atrial septal defect (ASD) and ventricular septal defect (VSD) are the two structural abnormalities. Atrial septal defect, or ASD, is caused by a deficiency in the atrial septum leading to a failure of overlap resulting in a hole in the atrial septum. Ventricular septal defect, or VSD, occurs during pregnancy due to deficiencies in the septum that separates the left and right ventricles leading to a hole in the septum. Occluder devices are recommended for the treatment of atrial septal defects (ASD) and ventricular septal defects (VSD). This device releases a self-expandable nitinol mesh that prevents blood flow through the atrial hole. Over time, heart tissue develops over the nitinol mesh to fully occlude the defect.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Structural Heart Occlusion Devices market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Structural Heart Occlusion Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Structural Heart Occlusion Devices market.
• Competitive dynamics insights and trends provided Structural Heart Occlusion Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Abbott Laboratories, AtriCure Inc, Lifetech Scientific Corporation, Occlutech GmbH, pfm medical ag, W. L. Gore & Associates Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Structural Heart Occlusion Devices market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Structural Heart Occlusion Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Structural Heart Occlusion Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Structural Heart Occlusion Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Structural Heart Occlusion Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable